Beijing Closes Talks | Treasury Markets Shift | Apple Alliance Weakens

Stocks opened lower after another record-setting session Thursday. 

Tech and semiconductor names led the pullback early, pressuring Nasdaq futures the most. Investors are still focused on the U.S.-China summit and waiting for clearer signals on trade and chip policy. 

The Dow recently reclaimed 50,000 while the S&P pushed above 7,500 for the first time. 

Cerebras continued climbing after its IPO debut, while SpaceX filing headlines kept speculative AI momentum active.

AI still drives index strength. Broader participation continues weakening beneath headline records.

Right now, investors have a chance to get in on Med-X before its planned Nasdaq listing — at just $4/share.

Once public markets open, broader demand and momentum take over. That early gap is where opportunity lives.

Here's what's already in place:

So what does Med-X actually do?

They're replacing traditional chemical pesticides with plant-based, safer alternatives — operating across 41 markets with millions in sales.

Global demand for sustainable pest control is surging. We've seen how emerging sectors start quietly — SaaS, telehealth — then explode once the market catches on.

Explore Med-X and become a shareholder at $4/share

Disclosures:This is a paid advertisement for Med-X's Regulation A+ Offering. Please read the offering circular at invest.medx-rx.com

Trump and Xi spent two days in Beijing. When it ended, both governments published their version of what happened. The two versions do not match.

Washington called it a trade reset. The wins included 200 Boeing (BA) aircraft orders, renewed U.S. beef import permits, and joint language that the Strait of Hormuz must remain open. Trump also invited Xi to Washington on September 24.

Beijing framed the same meeting as the start of a long-term framework designed to lock Trump into predictable behavior on the record. Xi warned Trump directly on Taiwan, saying mishandling it would cause the two countries to "collide or even clash." Trump did not publicly respond.

What Each Side Got

China agreed not to arm Iran but kept buying Iranian oil. Xi's Taiwan warning was the stated price for offering stability. Trump's silence was the answer Beijing wanted. Silence on Taiwan at a bilateral summit is not neutrality. It is a public record Beijing can point to.

The Gap

Washington left with transactions. Beijing left with a framework that limits future U.S. action. Both sides got something real. They just got very different things.

Kevin Warsh was confirmed as Fed chair. The bond market did not wait for his first meeting. It started testing his position immediately after confirmation.

The 30-year Treasury yield crossed 5 percent. The 2-year yield touched 4 percent, sitting above the Fed's own policy rate target of 3.7 percent. When the 2-year trades above the Fed's target, the market is signaling that the Fed's rate is too low for current conditions.

Rate hike odds by year-end are approaching 40 percent. One portfolio manager put it plainly: Warsh wanted the option to cut rates and the bond market just removed it before he started.

His first meeting is June 16. Every option he has on the dot plot carries a cost. The bond market is not waiting for him to decide.

The Bind

Strait language in the Beijing joint statement that pulls oil lower gives Warsh a small window before June. Its absence tightens his starting position before he chairs a single meeting.

That’s what the media wants you to focus on.

But behind the scenes, it seems President Trump is quietly preparing something far more shocking — that will leave even his most loyal MAGA patriots stunned. 

It’s NOT being debated on cable news or on X.

But it could make you enormously rich in 2026. Click here to find out why immediately.

Cerebras (CBRS) surged 68 percent on its first day of trading, closing at roughly $95 billion in market value against a $185 IPO price. That result set the demand floor for every AI infrastructure IPO that follows.

The next one is now on a visible calendar. SpaceX is targeting a June 8 roadshow start. That requires filing its prospectus at least 15 days before, meaning a disclosure as early as next week.

SpaceX is targeting $70 to $75 billion in gross proceeds. That is more than twice Saudi Aramco's 2019 record. Advisers are reaching brokers in the U.K., Japan, and Canada because no single U.S. investor base can absorb $70 billion alone.

What the Prospectus Reveals

Cerebras validated appetite at $56 billion. SpaceX is asking for a valuation more than 20 times larger.

The Test

Cerebras gave AI infrastructure a public price. SpaceX's prospectus shows whether that price holds at a completely different scale.

Three AI-assisted cyberattacks were confirmed in a single week. Monday was Google's zero-day. Tuesday was the Canvas school breach. The third involved security researchers using techniques from Anthropic's Mythos to break Apple's (AAPL) most advanced security feature in five days.

Apple described that feature in September as "the culmination of an unprecedented design and engineering effort, spanning half a decade." It fell in less than a week. Earlier this year, Mythos found over 100 high-severity Firefox bugs in two weeks, a task that normally takes two months.

Three attacks. One week. All documented. The White House's executive order debate is no longer about preventing a hypothetical. It is responding to a pattern.

The Acceleration

If the executive order draft cites any of this week's three confirmed incidents, the restrictive side of the internal White House debate has won. That would show up in the final order's specific language.

Wall Street’s big money is already moving, quietly building positions in a handful of stocks before the next rally.

Our analysts tracked the flows and found 10 companies leading the charge.

Some are household names. Others are under-the-radar innovators about to break out.

Together, they form the Post-Rate-Cut Playbook smart investors are following right now.

See Wall Street’s Top 10 Stocks for the Second Half of 2026,  free before it moves behind the paywall >>

OpenAI's two-year partnership with Apple gave ChatGPT privileged placement on the iPhone. Apple has roughly 1.4 billion active devices. That placement was the most valuable consumer distribution channel available to any AI company outside Google's own products.

That relationship has now broken down. OpenAI's lawyers are working with an outside firm on potential action, specifically notifying Apple of a contract breach without filing a full lawsuit. Renegotiation attempts have stalled.

The trigger is Apple testing both Anthropic's Claude and Google's (GOOGL) Gemini as Siri alternatives. A multi-provider model removes OpenAI's unique position entirely.

The legal move stops short of a lawsuit deliberately. Filing a full suit during active IPO preparation carries regulatory and reputational risks OpenAI cannot afford right now.

The Beneficiary

Anthropic wins this dispute regardless of outcome. Apple testing Claude means Anthropic gains iPhone access whether OpenAI wins the renegotiation or not. Apple's June developer conference is the first public moment that integration could be announced.

The week ended with every major position under simultaneous pressure.

Beijing produced two different stories about the same two days. The bond market raised rates before Warsh chaired a meeting. Apple's toughest security fell to AI in five days. And OpenAI's iPhone access became a legal question.

Everything settled at the start of the week looks different now.